Low-dose CT lung cancer screening centers serve high-risk populations through annual exams, following guidelines such as USPSTF. This model covers both fixed-site and mobile operations, mapping the entire patient journey from acquisition and scheduling to scan, radiologist reporting, and recall tracking. It splits patient pathways into initial screening and diagnostic follow-up after a positive finding, each with its own billing, capacity, and revenue logic.
Operationally, the model captures scan-slot throughput with realistic allowances for room turnover, scheduled preventive maintenance, no-show rates, and seasonal demand variations. The false-positive recall rate (inherent in LDCT screening) is modeled as a dynamic driver that generates downstream diagnostic CT volumes, incremental professional fees, and associated resource consumption – making the interplay between screening accuracy and center profitability transparent.
The capital structure includes the CT scanner (purchase or finance lease), radiation shielding, IT/PACS, and facility build-out. Operating costs are detailed: radiographer shifts, radiologist contracts (in-house or teleradiology), service agreements treated as a time-varying percentage of equipment cost, and ACR/MQSA compliance. The model indicates the investment magnitude at a medium-scale level, offering an indicative order of magnitude rather than a final budget.